Seaport Therapeutics, Inc. (SPTX) stock
SPTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 2, 2026
$18.17−0.95 (-4.97%)
Close on Nov 17, 2026Market cap $972.65MP/E –Yield –
Seaport Therapeutics cash
Cash and short-term investments held at the end of each period.
Seaport Therapeutics's cash was $290.43M at Sep 30, 2026. For fiscal 2025 it was $215.98M.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $215.98M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $290.43M | – |
| Q2 FY2026 | Jun 30, 2026 | $273.31M | – |
| Q1 FY2026 | Mar 31, 2026 | $182.61M | – |
| Q4 FY2025 | Dec 31, 2025 | $215.98M | – |
See a number that looks wrong?